Posted in | News | Materials Research | Building and Construction | Fibers

James Hardie Divest Gypsum Business

Mar 18 2002

Related Stories

James Hardie have announced that they have agreed to sell their US-based gypsum operations for US$345million to UK manufacturer BPB plc. This follows their decision to sell their Las Vegas gypsum mine for US$50 million late last year. The sale price for the gypsum operation is 30% above the book value for assets and represents a good return for shareholders.

Although gypsum business has produced strong returns, the decision was made to divest the business so that they could concentrate on fibre cement business for building and construction applications. They intend to increase their research and development funding to this sector of the organisation to approximately US$21 million, which represents an increase of about 50%.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback